UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
     
 
Washington, D.C.  20549
 
     
 
FORM 12b-25
 
   
SEC FILE NUMBER
   
000-54949
 
NOTIFICATION OF LATE FILING
 
   
CUSIP NUMBER
     
 
(Check One):
Form 10-K
Form 20-F
Form 11-K
Form 10-Q
Form 10-D
Form N-SAR
Form N-CSR
 
For Period Ended:  March 31, 2016
Transition Report on Form 10-K
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q
Transition Report on Form N-SAR
For the Transition Period Ended: _____________________________________________________________

Read Instruction (on back page) Before Preparing Form.  Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 

PART I -- REGISTRANT INFORMATION
 
BIOADAPTIVES, INC.
F ull Name of Registrant
 
 
Former Name if Applicable
 
1015 S. CIMMARON RD.
Ad dress of Principal Executive Office ( Street and Number)
 
LAS VEGAS, NV  89145
Cit y, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.  (Check box if appropriate)

 
(a)
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.


PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.  (Attach extra sheets if needed.)

The Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2016 could not be filed because the Company has limited financial resources and personnel and was unable to timely complete and verify its financial statements.

PART IV -- OTHER INFORMATION

(1) Na me and telephone number of person to contact in regard to this notification

Christopher G. Hall
 
888
 
280-0789
(Name)
 
(Area Code)
 
(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s).
 
  Yes
  No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
 
Yes
  No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.






BioAdaptives Inc.
( Nam e of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.


Date:
May 16, 2016
By
/s/ Christopher G. Hall
     
Christopher G. Hall
     
President

Bioadaptives (PK) (USOTC:BDPT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Bioadaptives (PK) Charts.
Bioadaptives (PK) (USOTC:BDPT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Bioadaptives (PK) Charts.